EAST LINDSEY MEDICAL GROUP
153 NEWMARKET, LOUTH
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 32 | 45 | 71.1% | |
| HF 4 | 2011 | 30 | 45 | 66.7% | |
| HF 4 | 2012 | 31 | 42 | 73.8% | |
| HF 4 | 2013 | 31 | 43 | 72.1% | |
| HF004 | 2014 | 24 | 32 | 75.0% | |
| HF004 | 2015 | 21 | 27 | 77.8% | |
| HF004 | 2016 | 17 | 23 | 73.9% | |
| HF004 | 2017 | 17 | 21 | 81.0% | |
| HF004 | 2018 | 19 | 23 | 82.6% | |
| HF004 | 2019 | 35 | 38 | 92.1% | |
| HF004 | 2020 | 49 | 56 | 87.5% | |
| HF006 | 2021 | 80 | 89 | 89.9% | |
| HF006 | 2022 | 92 | 103 | 89.3% | |
| HF006 | 2023 | 81 | 93 | 87.1% |
